Europe Stem Cell Market Forecast 2018-2026

Publisher Name :
Date: 27-Jul-2018
No. of pages: 88
This report is available at 15% Discount for Single User License and 25% Discount for Corporate Users License till 31 January 2020. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Key Findings

Different cultures have varying attitudes toward the desirability of using stem cells. However, the European market has always been supportive of biotechnological research and is blessed with a number of institutes and universities that are engaged in the same. Driven by this fact, the Europe stem cell market is anticipated to register a CAGR of 9.45% by the end of the forecast period of 2018-2026.

Market Insights

Several European markets analyzed in this region include UK, Germany, France, Spain, Italy and rest of Europe. In the year 2017, UK and Germany were significant contributors to this region. In fact, the UK has played a critical role in the first fully approved bone marrow transplantation using stem cell therapy. On the other hand, the German market is majorly being driven by its advanced healthcare facility and growing elderly population

Competitive Insights

The Europe stem cell market is developing owing to the presence of eminent market companies like Becton Dickinson, Ge Healthcare, Fibrocell Science Inc, Celgene Corporation, Thermo Fisher Vericel Corporation (Formerly Aastrom Bioscience), Kangstem Biotech Ltd, Biotime Inc, Corestem Inc, Corning Inc., Brainstorm Cell Therapeutics, Stemedica Cell Technologies Inc and Cytori Therapeutics.

This report is available at 15% Discount for Single User License and 25% Discount for Corporate Users License till 31 January 2020. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Europe Stem Cell Market Forecast 2018-2026

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Regenerative Medicine Is The Emerging Branch of Medical Science
3.2.2. Use of Adult Stem Cells Has Been Significant
4. Market Determinants
4.1. Market Driver
4.1.1. Potential of Stem Cells In Regenerative Medicine
4.1.2. Key To Anti-Ageing And Prolonging Life
4.1.3. Increasing R&D Investments In Adult Stem Cell Research
4.1.4. Ease of Administration
4.1.5. Reduced Risk of Tissue Rejection In Transplants
4.2. Market Restraints
4.2.1. Safety Issues
4.2.2. Ethical Issues
4.3. Opportunities
4.3.1. Technological Innovations
4.3.2. Emerging Application As A Drug Discovery Tool
4.3.3. Other Promising Applications
4.4. Market Challenges
4.4.1. Stringent Government Regulations
5. Market Segmentation
5.1. Market By Products 2018-2026
5.1.1. Adult Stem Cell Market
5.1.1.1. Hematopoietic Stem Cell Market
5.1.1.2. Mesenchymal Stem Cell Market
5.1.1.3. Neural Stem Cell Market
5.1.1.4. Dental Stem Cell Market
5.1.1.5. Umbilical Cord Stem Cell Market
5.1.2. Human Embryonic Stem Cell
5.1.3. Induced Pluripotent Stem Cell Market
5.1.4. Rat Neural Stem Cell Market
5.2. Market By Technology 2018-2026
5.2.1. Stem Cell Acquisition
5.2.1.1. Stem Cell Bone Marrow Market
5.2.1.2. Stem Cell Apheresis Market
5.2.1.3. Umbilical Cord Blood Market
5.2.2. Stem Cell Production
5.2.2.1. Therapeutic Cloning
5.2.2.2. Ivf Stem Cell
5.2.2.3. Stem Cell Culture
5.2.3. Stem Cell Cryopreservation
5.2.4. Stem Cells Expansion And Sub-Culture
5.3. Market By Application 2018-2026
5.3.1. Regenerative Medicine
5.3.2. Drug Discovery And Development
6. Key Analytics
6.1. Porter's Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitute Products Or Services
6.1.3. Bargaining Power of Buyer
6.1.4. Bargaining Power of Supplier
6.1.5. Intensity of Competitive Rivalry
6.2. Value Chain Analysis
6.3. Opportunity Matrix
6.4. Key Buying Criteria
6.4.1. High Price
6.4.2. Efficacy
6.4.3. Application And Effectiveness
6.4.4. Accuracy
6.5. Pest Analysis
6.6. History of Stem Cell
6.7. Patent Analysis
6.7.1. Stem Cell Patent In Europe
6.8. Regulatory Frame Work
7. Geographical Analysis
7.1. Europe
7.1.1. The United Kingdom
7.1.2. France
7.1.3. Germany
7.1.4. Spain
7.1.5. Italy
7.1.6. Rest of Europe
8. Company Profile
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.2. Becton Dickinson
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Biotime Inc
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Brainstorm Cell Therapeutics
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiatives
8.5. Celgene Corporation
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Cellular Dynamics International (Holding Company Fujifilm)
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiatives
8.7. Cellular Engineering Technologies Inc.
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Corestem Inc
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Corning Inc.
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Cytori Therapeutics
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Fibrocell Science Inc
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Scot Analysis
8.11.4. Strategic Initiatives
8.12. Ge Healthcare
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Kangstem Biotech Ltd
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Strategic Initiatives
8.14. Stemedica Cell Technologies Inc
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Strategic Initiatives
8.15. Stryker Corporation
8.15.1. Company Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
8.16. Takara Holdings Inc.
8.16.1. Company Overview
8.16.2. Product Portfolio
8.16.3. Scot Analysis
8.16.4. Strategic Initiatives
8.17. Thermo Fisher
8.17.1. Company Overview
8.17.2. Product Portfolio
8.17.3. Scot Analysis
8.17.4. Strategic Initiatives
8.18. Vericel Corporation (Formerly Aastrom Bioscience)
8.18.1. Company Overview
8.18.2. Product Portfolio
8.18.3. Scot Analysis
8.18.4. Strategic Initiatives

List of Tables

Table 1 Europe Stem Cell Market 2018-2026 ($ Million)
Table 2 Europe Stem Cells Market By Products 2018-2026 ($ Million)
Table 3 Europe Stem Cell Market In Adult Stem Cell 2018-2026 ($ Million)
Table 4 Europe Stem Cell Market In Adult Stem Cell By Types 2018-2026 ($ Million)
Table 5 Europe Adult Stem Cell Market In Hematopoietic Stem Cell 2018-2026 ($ Million)
Table 6 Europe Adult Stem Cell Market In Mesenchymal Stem Cell 2018-2026 ($ Million)
Table 7 Europe Adult Stem Cell Market In Neural Stem Cell 2018-2026 ($ Million)
Table 8 Europe Adult Stem Cell Market In Dental Stem Cell 2018-2026 ($ Million)
Table 9 Europe Adult Stem Cell Market In Umbilical Cord Stem Cell 2018-2026 ($ Million)
Table 10 Europe Stem Cell Market In Human Embryonic Stem Cell 2018-2026 ($ Million)
Table 11 Europe Stem Cells Market In Induced Pluripotent Stem Cell 2018-2026 ($ Million)
Table 12 Europe Stem Cell Market In Rat Neural Stem Cell 2018-2026 ($ Million)
Table 13 Europe Stem Cell Market By Technology 2018-2026 ($ Million)
Table 14 Europe Stem Cell Market In Acquisition By Types 2018-2026 ($ Million)
Table 15 Europe Stem Cell Market In Acquisition 2018-2026 ($ Million)
Table 16 Europe Stem Cell Acquisition Market In Bone Marrow By Geography 2018-2026 ($ Million)
Table 17 Europe Stem Cell Acquisition Market In Cell Apheresis 2018-2026 ($ Million)
Table 18 Europe Stem Cell Acquisition Market In Umbilical Cord Blood 2018-2026 ($ Million)
Table 19 Europe Stem Cell Market In Production By Types 2018-2026 ($ Million)
Table 20 Europe Stem Cell Market In Production 2018-2026 ($ Million)
Table 21 Europe Stem Cell Production Market In Therapeutic Cloning 2018-2026 ($ Million)
Table 22 Europe Stem Cell Production Market In Ivf Stem Cell 2018-2026 ($ Million)
Table 23 Europe Stem Cell Production Market In Stem Cell Culture 2018-2026 ($ Million)
Table 24 Europe Stem Cell Market In Stem Cell Cryopreservation 2018-2026 ($ Million)
Table 25 Europe Stem Cell Market In Stem Cell Expansion And Sub-Culture 2018-2026 ($ Million)
Table 26 Europe Stem Cells Market By Application 2018-2026 ($ Million)
Table 27 Europe Stem Cells Market In Regenerative Medicine 2018-2026 ($ Million)
Table 28 Europe Stem Cell Market In Drug Discovery And Development 2018-2026 ($ Million)
Table 29 Europe Stem Cell Market By Country 2018-2026 (In $ Million)
Figures List
Figure 1 Europe Stem Cell Market 2018-2026 ($ Million)
Figure 2 Europe Stem Cell Market In Adult Stem Cell 2018-2026 ($ Million)
Figure 3 Europe Adult Stem Cell Market In Hematopoietic Stem Cell 2018-2026 ($ Million)
Figure 4 Europe Adult Stem Cell Market In Mesenchymal Stem Cell 2018-2026 ($ Million)
Figure 5 Europe Adult Stem Cell Market In Neural Stem Cell 2018-2026 ($ Million)
Figure 6 Europe Adult Stem Cell Market In Dental Stem Cell 2018-2026 ($ Million)
Figure 7 Europe Adult Stem Cell Market In Umbilical Cord Stem Cell 2018-2026 ($ Million)
Figure 8 Europe Stem Cell Market In Human Embryonic Stem Cell 2018-2026 ($ Million)
Figure 9 Europe Stem Cells Market In Induced Pluripotent Stem Cell 2018-2026 ($ Million)
Figure 10 Europe Stem Cell Market In Rat Neural Stem Cell 2018-2026 ($ Million)
Figure 11 Europe Stem Cell Market In Acquisition 2018-2026 ($ Million)
Figure 12 Europe Stem Cell Acquisition Market In Bone Marrow 2018-2026 ($ Million)
Figure 13 Europe Stem Cell Acquisition Market In Apheresis 2018-2026 ($ Million)
Figure 14 Europe Stem Cell Acquisition Market In Umbilical Cord Blood 2018-2026 ($ Million)
Figure 15 Europe Stem Cell Market In Production 2018-2026 ($ Million)
Figure 16 Europe Stem Cell Production Market In Therapeutic Cloning 2018-2026 ($ Million)
Figure 17 Europe Stem Cell Production Market In Ivf Stem Cell 2018-2026 ($ Million)
Figure 18 Europe Stem Cell Production Market In Stem Cells Culture 2018-2026 ($ Million)
Figure 19 Europe Stem Cell Market In Stem Cells Cryopreservation 2018-2026 ($ Million)
Figure 20 Europe Stem Cell Market In Stem Cell Expansion And Sub-Culture 2018-2026 ($ Million)
Figure 21 Europe Stem Cells Market In Regenerative Medicine 2018-2026 ($ Million)
Figure 22 Europe Stem Cell Market In Drug Discovery And Development 2018-2026 ($ Million)
Figure 23 The United Kingdom Stem Cell Market 2018-2026 (In $ Million)
Figure 24 France Stem Cell Market, 2018-2026 (In $ Million)
Figure 25 Germany Stem Cell Market 2018-2026 (In $ Million)
Figure 26 Spain Stem Cell Market 2018-2026 (In $ Million)
Figure 27 Italy Stem Cell Market 2018-2026 (In $ Million)
Figure 28 Rest of Europe Stem Cell Market 2018-2026 (In $ Million)
Figure 29 Stem Cell
  • Global Animal Stem Cell Therapy Market Study 2016-2026, by Segment (Dogs, Horses,) , by Market (Veterinary Hospitals, Research Organizations) , by Company (MediVet Biologic, VETSTEM BIOPHARMA,)
    Published: 11-Nov-2019        Price: US 1800 Onwards        Pages: 61
    Summary Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells......
  • 2017-2025 World Cancer Stem Cell Therapy Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 30-Oct-2019        Price: US 2800 Onwards        Pages: 98
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Cancer Stem Cell Therapy , covering Glob......
  • Global Stem Cell Assay Market Professional Survey Report 2019
    Published: 29-Oct-2019        Price: US 3500 Onwards        Pages: 106
    The global Stem Cell Assay market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Stem Cell Assay volume and value at global level, regional level and company level. From a global perspective, this report represents overall Stem Cell Assay market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export ......
  • 2017-2025 World Autologous Cell Therapy Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 25-Oct-2019        Price: US 2800 Onwards        Pages: 104
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Autologous Cell Therapy , covering Global total ......
  • Global Cancer Stem Cell Therapy Market Professional Survey Report 2019
    Published: 25-Oct-2019        Price: US 3500 Onwards        Pages: 105
    The global Cancer Stem Cell Therapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer Stem Cell Therapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Stem Cell Therapy market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, ap......
  • Global and China Cancer Stem Cell Therapy Market Research by Company, Type & Application 2013-2025
    Published: 14-Oct-2019        Price: US 2000 Onwards        Pages: 64
    Summary Market Segment as follows: By Type - Autologous Stem Cell Transplants - Allogeneic Stem Cell Transplants - Syngeneic Stem Cell Transplants - Others By Application - Hospital - Clinic - Medical Research Institution - Others By Company - AVIVA BioSciences - AdnaGen - Advanced Cell Diagnostics - Silicon Biosystems The main contents of the rep......
  • Global and China Autologous Cell Therapy Market Research by Company, Type & Application 2013-2025
    Published: 12-Oct-2019        Price: US 2000 Onwards        Pages: 75
    Summary Market Segment as follows: By Type - Bone Marrow - Epidermis By Application - Neurology - Orthopedics - Cancer - Wound Healing - CVD - Autoimmune - Others By Company - BioTime, Inc. - BrainStorm Cell Therapeutics - Caladrius Biosciences, Inc. - Fibrocell Science, Inc. - Opexa Therapeutics, Inc. - Pharmicell Co., Inc. ......
  • Global Cancer Stem Cell Therapy Market Study 2016-2026, by Segment (Autologous Stem Cell Transplants, Allogeneic Stem Cell Transplants,), by Market (Hospital, Clinic,), by Company (AVIVA BioSciences, AdnaGen,)
    Published: 28-Sep-2019        Price: US 1800 Onwards        Pages: 62
    Summary The global Cancer Stem Cell Therapy market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): - Autologous Stem Cell Transplants - Allogeneic Stem Cell Transplants - Syngeneic Stem Cell Transplants - Others Demand Coverage (Market Size & Forecast, Consumer Distribution): - Hospital - Clinic......
  • Global Induced Pluripotent Stem Cells (iPSCs) Market Size, Status and Forecast 2019-2025
    Published: 26-Sep-2019        Price: US 3900 Onwards        Pages: 91
    Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. Fujifilm Holding Corporation (CDI) was the global largest Players in Induced Pluripotent Stem Cells (iPSCs) industry,with the market share of 39% in 2018,followed by Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL. In 2018, the global In......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs